| Galaxy Next Generation (OTC: FLCRD) Completed Its 165th Interactive Flat Panel Display Installation for Carroll County School System |
| |
|
Galaxy Next Generation (OTC: FLCRD), a U.S. distributor of interactive learning technology hardware and software that create fully collaborative instructional environments, announced the completed installation of the 165th G2 SAM series interactive flat panel display for the Carroll County School Systems in Carroll County, Georgia.
Why It Matters: The multi-phased project includes outfitting each of the district’s approximately 800 classrooms with Galaxy’s G2 SAM series interactive panels. A variety of panel sizes are included in the project, which encompasses classrooms in 12 elementary schools, six middle schools, and six high schools. The project has generated approximately $565,000 in revenue to date. Additional classroom installations are anticipated in average orders of 5 to 10 units.
Key Quote: “Our work with Carroll County is just one example of what is driving Galaxy’s growth. With more than 22 distributors nationally, and a growing portfolio of in-demand products, we expect to generate between $20 million and $22 million in revenue in the fiscal year ending June 30, 2019, up more than 200% over the prior year results, with approximately $3 million in net income.” – Gary LeCroy, Founder and CEO
What’s Next: Further growth could come from potential acquisitions, such as the LOI Galaxy announced in July to acquire KLIK Communications, which alone could add $3 million in revenue for the year. Overall, we believe Galaxy is building a solid foundation for sustained shareholder value improvement and represents a compelling value at current levels. The company recently completed a reverse split and will trade under the ticker FLCRD through mid-October.
Disclosure
Galaxy Next Generation (OTC: FLCRD) is a client of RedChip Companies, Inc. FLCRD agreed to pay RedChip Companies, Inc. a monthly cash fee for 4 months of investor awareness services.
|
|
| |
|
| Nemaura Medical (NASDAQ: NMRD) Signs LOI for SugarBEAT® Commercial Launch in Qatar |
| |
|
Nemaura Medical (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by persons with diabetes and pre-diabetics, this week announced that it has signed a non-binding letter of intent for an exclusive licensing agreement with Al-Danah Medical Co for the commercial launch of sugarBEAT® in Qatar.
Why It Matters: Qatar has one of the world’s highest prevalence of diabetes, with 17% of the population diabetic and 23% pre-diabetic, and also has the world’s highest GDP per capita, and is therefore a significant potential market for sugarBEAT®. Al-Danah Medical Company, part of the Almana Group, is a leading medical product distributor in Qatar, representing multiple global brands. CGM adoption is growing rapidly amongst diabetics, with the global total addressable market estimated at $82Bn annually. The U.S. is the largest single market, where CGM is being used by an estimated 2.6% (630,000 users) of all diagnosed diabetics in 2018, representing annualized growth of 117%.
What’s Next: CE Mark approval of sugarBEAT® is expected in the near-term, which should set the stage for ongoing revenue growth. Longer-term, future US sales upon FDA approval will provide an even greater boost. Last week, Nemaura announced interim analysis of results from the first of a number of planned studies in support of a submission to the FDA for approval. The results were in line with the company’s expectations and compare favorably with competitor products.
Disclosure
Nemaura Medical (NASDAQ: NMRD) is a client of RedChip Companies. NMRD agreed to pay RedChip a monthly cash fee for investor awareness services.
|
|
| |
|
| Asia Trades Higher As Investors Shrug Off Escalating U.S.-China Trade Tensions |
| |
|
Asia markets mostly rose on Wednesday as investors took an escalation of trade tensions between the U.S. and China in their stride.
The U.S administration announced that it would implement a 10% tariff on $200 billion worth of Chinese imports. In response, the China announced tariffs on 5,000 U.S products, estimated about $60 billion.
The escalating tensions have drawn attention to the leverage that China holds as the largest foreign creditor to the U.S. According to U.S. government data published Tuesday, China’s ownership of U.S. Treasuries fell to a six-month low in July.
|
|
| |
|
| Interpace Diagnostics (NASDAQ: IDXG) Supports Research Efforts of Pancreatic and Thyroid Cancer Patient Advocacy Groups |
| |
|
Interpace Diagnostics Group (NASDAQ: IDXG), a fully integrated commercial and bioinformatics company that provides beneficial molecular diagnostic tests and pathology services that improve patient diagnosis and management, announced today that the Company will participate in several local events in support of the following patient advocacy groups: Lustgarten Foundation Pancreatic Cancer Research (The Lustgarten Foundation), Thyroid, Head and Neck Cancer (THANC) Foundation, and Pancreatic Cancer Action Network (PanCAN).
The Backstory: Interpace is a fully integrated commercial and bioinformatics company that provides clinically useful molecular and related first line diagnostic tests and pathology services for evaluating risk of cancer by leveraging the latest technology in personalized medicine for improved patient diagnosis and management.
|
|
| |
|
| Catasys (NASDAQ: CATS) Expands OnTrak-A Solution to Iowa and Nebraska with Leading National Health Plan |
| |
- National Plan Expands OnTrak-A into 10th and 11th States
- OnTrak-A Offered to Both Commercial and Medicare Advantage Plan Members
- With This Launch, OnTrak Is Now Available in 22 States
Catasys (NASDAQ: CATS), a leading AI and technology-enabled healthcare company, today announced that it has expanded its OnTrak-A solution into Iowa and Nebraska with one of the nation’s leading health plans, which is the second largest plan in both states.
Eligible commercial and Medicare Advantage plan members in these states are now able to participate in OnTrak-A, an integrated 52-week program that identifies, engages and treats members with unaddressed behavioral health conditions that impact co-morbid medical conditions, such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure, resulting in high medical costs. With this expansion, the OnTrak program is now available in 22 states to members of major health plans.
The Backstory: Catasys harnesses proprietary big data predictive analytics, artificial intelligence and telehealth, combined with human intervention, to deliver improved member health and cost savings to health plans through integrated technology enabled treatment solutions. It is our mission to provide access to affordable and effective care, thereby improving health and reducing cost of care for people who suffer from the medical consequences of behavioral health conditions; helping these people and their families achieve and maintain better lives.
Disclosure
Catasys (NASDAQ: CATS) is a client of RedChip Companies, CATS agreed to pay RedChip Companies, a monthly cash fee for RedChip investor awareness services and consulting services.
|
|
| |
|
| Pennsylvania American Water (NYSE: AWK) Announces Agreement to Acquire Pike County Wastewater System |
| |
|
Pennsylvania American Water, a subsidiary of American Water (NYSE: AWK), announced today that it has signed an agreement to acquire the wastewater assets of the Delaware Sewer Company in Delaware Township, Pike County. The wastewater system serves approximately 40 customers, and the transaction is valued at $61,700.
The Backstory: Pennsylvania American Water, a subsidiary of American Water (NYSE: AWK), is the largest investor-owned water utility in the state, providing high-quality and reliable water and/or wastewater services to approximately 2.4 million people. With a history dating back to 1886, American Water is the largest and most geographically diverse U.S. publicly traded water and wastewater utility company. The company employs more than 7,100 dedicated professionals who provide regulated and market-based drinking water, wastewater and other related services to an estimated 14 million people in 45 states and Ontario, Canada. American Water provides safe, clean, affordable and reliable water services to our customers to make sure we keep their lives flowing. For more information, visit amwater.com and follow American Water on Twitter, Facebook and LinkedIn.
|
|
| |
|
| |
| Quote of the Week |
| |
"Invest in something you can get your arms around and be very conservative, own enough stock so that you are not putting all your eggs in one basket."
-Dave Maley, Manager of Ariel Microcap Funds-Microcap Superstar |
|
|
| About RedChip |
| |
| RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. |
| |
| RedChip Disclosure |
| |
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov. |
|
| |
|
|
| |
|
Copyright © 2018 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.
If you received this email by mistake you can unsubscribe from all emails.
|
|
|
|
|
|
|
| |
